Vor Biopharma, announced the promotion of Tirtha Chakraborty, PhD, to Chief Scientific Officer. Dr. Chakraborty brings significant expertise in hematology and genetic engineering to the company’s top science position. Dr. Chakraborty joined Vor in October 2019 from Sana Biotechnology, where he served as the Vice President of Cell Therapy Research. Dr. Chakraborty brings significant expertise in hematology and genetic engineering to the company’s top science position.